Quick Links

 Selected Publications

Smith, D., Sætrom P., Snøve, O., Lundberg C., Rivas, G., Glackin, C., and Larson G. (2008) Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.  BMC Bioinformatics 9: 63-77.

Larson, G.P.
, Ding, Y., et al. (2005) Genetic Linkage of Prostate Cancer Risk to the Chromosome 3 Region Bearing FHIT. Ca Res. 65(3):805-814.

Tamimi, R. M., Hankinson, S. E., Ding, S., Gagalang, V., Larson, G. P., Spiegelman, D., Colditz, G. A., Krontiris, T. G., Hunter, D. J (2003) The HRAS1 variable number of tandem repeats and risk of breast cancer. Ca Epid. Biomrks Prev. 12:1528-30.

Beaulieu, M., Larson, G., Geller, L, Flanagan, S., Krontiris, T. (2001) PCR Candidate region mismatch scanning: adaptation to quantitative, high-throughput genotyping. Nuc. Acids Res. 29(5):1114-24.

Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG (2000) The HRAS1 minisatellite locus and risk of ovarian cancer. CA Res 60:259-61.

Larson GP, Ding S, Lafreniere RG, Rouleau GA, Krontiris TG (1999) Instability of the EPM1 minisatellite. Hum Mol Genet 11:1985-8.

Ding S, Larson GP, Foldenauer K, Zhang G, Krontiris TG (1999) Distinct mutation patterns of breast cancer-associated alleles of the HRAS1 minisatellite locus. Hum Mol Genet 8:515-21.

Larson GP, Zhang G, Ding S, Foldenauer K, Udar N, Gatti RA, Neuberg D, Lunetta KL, Ruckdeschel JC, Longmate J, Flanagan S, Krontiris TG (1997) An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genet Test 1:165-70.

Westaway, S.K., Larson, GP, Zaia, J., and Rossi, J.J. (1995) A chimeric tRNAlys,3-ribozyme inhibits HIV replication following virion assembly . Nuc. Acids Res. Symp., RNA biology: RNA Protein Interactions: 194-199.

Zhou, C., Bahner, I., Larson, GP, Rossi, J.J., Zaia, J., Kohn, D.B. (1994) Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149: 33-49.

Larson, GP, Castanotto, D., Rossi, J., and Malafa, M. (1994) Isolation and functional analysis of a Kluyveromyces lactis RAP1 homolog. Gene 150:35-41.

Larson, GP, Rossi, J., and Bertrand, E. (1993) Designs for ribozymes as antiviral agents. In Methods: A Companion to Methods in Enzymology 5:19-27.

Larson, GP, and Rossi, J.J. (1991) Altered response to growth rate changes in Kluyveromyces lactis versus Saccharomyces cerevisiae as demonstrated by heterologous expression of ribosomal protein 59 (CRY1). Nuc. Acids Res. 19: 4701-4707.

Deshler, J., Kaplan, B., Larson, GP, and Rossi, J. (1990) The chemical synthesis and some uses of oligonucleotides in biological research. In Meth. in Nucleic Acids Res., pp 21-44 (Karam, J.D., Chao, L., and Warr, G.W., eds.) CRC Press. Boca Raton, FL.

Deshler, J., Larson, GP, and Rossi, J.J., (1990) Kluyveromyces lactis maintains Saccharomyces cerevisiae intron-encoded splicing signals. Mol. Cell. Biol. 9: 2208-2213.

Ng, R., Domdey, H., Larson, GP, Rossi, J.J., and Abelson, J., (1985) A test for intron function in the yeast actin gene. Nature 314: 183-184.

Larson, GP, Kaplan, B., and Rossi, J.J., (1984) The chemical synthesis of DNA and its uses in molecular biology. The Amer. Biol. Teacher, 46: 440-446.

Larson, GP, Itakura, K., Ito, H., and Rossi, J.J., (1983) Saccharomyces cerevisiae actin-Escherichia coli lacZ gene fusions: synthetic oligonucleotide mediated deletion of the 309 base pair intervening sequence in the actin gene. Gene, 22: 31-39.

Soberon, X., Rossi, J.J., Larson, GP, and Itakura, K., (1982) A synthetic, consensus sequence, prokaryotic promoter is functional. "Promoters: Structure and Function", pp 407-431, Prager Publishers. (Rodriguez, R.L. and Chamberlin, M.J., eds.).

Rossi, J.J., Schold, M., Larson, GP, and Wallace, B. (1982) Functional expression of a yeast ochre suppressor tRNA gene in Escherchia coli. Gene, 20: 423-432.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.